rss
Ann Rheum Dis 2009;68:416-419 doi:10.1136/ard.2008.095414
  • Clinical and epidemiological research

Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis

This article has been Unlocked
  1. B Tolusso1,
  2. D Frezza2,
  3. C Mattioli2,
  4. A L Fedele1,
  5. S Bosello1,
  6. F Faustini1,
  7. G Peluso1,
  8. V Giambra2,
  9. D Pietrapertosa1,
  10. A Morelli1,
  11. E Gremese1,
  12. M De Santis1,
  13. G F Ferraccioli1
  1. 1
    Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy
  2. 2
    Department of Biology Enrico Calef, University of Tor Vergata, Rome, Italy
  1. Professor G F Ferraccioli, Division of Rheumatology, School of Medicine, Catholic University of the Sacred Heart, Via Moscati 31, Rome 00168, Italy; gf.ferraccioli{at}rm.unicatt.it
  • Accepted 30 September 2008
  • Published Online First 24 October 2008

Abstract

Objective: To investigate the role of the HS1,2 enhancer polymorphisms as a new candidate marker for rheumatoid arthritis (RA) and to define the possible association with autoantibody positivity and clinical outcome.

Methods: Genomic DNA was obtained from two cohorts of patients with RA (100 with early RA (ERA) and 114 with longstanding RA (LSRA)) and from 248 gender-matched controls from the same geographical area. Clinical and immunological characteristics were recorded for all the patients.

Results: The percentage of the 2/2 genotype was higher in patients with ERA (27.0%), and in patients with LSRA (34.2%), than in controls (14.9%) (ERA: OR = 2.11 (95% CI 1.20 to 3.70) vs controls; LSRA: OR = 2.96 (95% CI 1.76 to 5.00) vs controls). A lower representation of allele *3 was present in patients with ERA (2.0%) than in controls (6.0%; OR = 0.32 (95% CI 0.11 to 0.91)). No significant associations were found between polymorphisms and autoantibodies positivity.

Conclusion: The HS1,2A allele *2 associates with early and longstanding RA.

Footnotes

  • Competing interests: None.

  • Funding: This research was supported by the funding of the Catholic University of Sacred Heart of Rome and University of Tor Vergata, Rome (MIUR PRIN N.20073RH73W_003).

  • Ethics approval: Ethics committee approval obtained.

This article has been Unlocked

This Article

  1. Free via Creative Commons: CC
  2. Abstract
  3. Full text
  4. PDF
  5. All versions of this article:
    1. ard.2008.095414v1
    2. 68/3/416 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.